Su He Wang

2.2k total citations
45 papers, 1.8k citations indexed

About

Su He Wang is a scholar working on Molecular Biology, Immunology and Polymers and Plastics. According to data from OpenAlex, Su He Wang has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Immunology and 12 papers in Polymers and Plastics. Recurrent topics in Su He Wang's work include Dendrimers and Hyperbranched Polymers (12 papers), Cell death mechanisms and regulation (11 papers) and NF-κB Signaling Pathways (6 papers). Su He Wang is often cited by papers focused on Dendrimers and Hyperbranched Polymers (12 papers), Cell death mechanisms and regulation (11 papers) and NF-κB Signaling Pathways (6 papers). Su He Wang collaborates with scholars based in United States, China and United Kingdom. Su He Wang's co-authors include James R. Baker, Xiangyang Shi, Mingwu Shen, Zhengyi Cao, Xisui Chen, Mary E. Van Antwerp, Patricia Arscott, Scott D. Swanson, James D. Bretz and Ge Song and has published in prestigious journals such as Science, Advanced Materials and The Journal of Immunology.

In The Last Decade

Su He Wang

45 papers receiving 1.7k citations

Peers

Su He Wang
Venkata Vamsi Krishna Venuganti India
Linlin Tang China
Omathanu Pillai India
Shraddha S. Nigavekar United States
Shiyan Guo China
Hanh Thuy Nguyen South Korea
Xinru You China
Bijay Kumar Poudel South Korea
Anna Mero Italy
Emilie Roger France
Venkata Vamsi Krishna Venuganti India
Su He Wang
Citations per year, relative to Su He Wang Su He Wang (= 1×) peers Venkata Vamsi Krishna Venuganti

Countries citing papers authored by Su He Wang

Since Specialization
Citations

This map shows the geographic impact of Su He Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su He Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su He Wang more than expected).

Fields of papers citing papers by Su He Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su He Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su He Wang. The network helps show where Su He Wang may publish in the future.

Co-authorship network of co-authors of Su He Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Su He Wang. A scholar is included among the top collaborators of Su He Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su He Wang. Su He Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Su He, Zhengyi Cao, Mohammad Farazuddin, et al.. (2024). A novel intranasal peptide vaccine inhibits non-small cell lung cancer with KRAS mutation. Cancer Gene Therapy. 31(3). 464–471. 9 indexed citations
2.
Dong, Tao, Chao Quan, Su He Wang, et al.. (2024). AFM41a: A Novel PAD2 Inhibitor for Sepsis Treatment—Efficacy and Mechanism. International Journal of Biological Sciences. 20(13). 5043–5055. 5 indexed citations
3.
Tang, Shengzhuang, Jesse Chen, Jayme Cannon, et al.. (2023). Delicate Hybrid Laponite–Cyclic Poly(ethylene glycol) Nanoparticles as a Potential Drug Delivery System. Pharmaceutics. 15(7). 1998–1998. 6 indexed citations
4.
Bhattacharjee, Somnath, Zhengyi Cao, Han Wang, et al.. (2020). Functionalized nanoparticles with targeted antibody to enhance imaging of breast cancer in vivo. Journal of Nanobiotechnology. 18(1). 135–135. 31 indexed citations
5.
Zong, Hong, et al.. (2016). Dendrimer antibody conjugate to target and image HER-2 overexpressing cancer cells. Oncotarget. 7(24). 36002–36013. 35 indexed citations
6.
7.
Wang, Su He, Lin Lü, Yongyi Fan, et al.. (2014). Characterization of a Novel Transgenic Mouse Tumor Model for Targeting HER2+ Cancer Stem Cells. International Journal of Biological Sciences. 10(1). 25–32. 13 indexed citations
8.
Shen, Mingwu, Hongdong Cai, Xifu Wang, et al.. (2012). Facile one-pot preparation, surface functionalization, and toxicity assay of APTS-coated iron oxide nanoparticles. Nanotechnology. 23(10). 105601–105601. 117 indexed citations
9.
Wang, Su He, Yongyi Fan, Paul E. Makidon, Zhengyi Cao, & James R. Baker. (2012). Induction of Immune Tolerance in Mice with A Novel Mucosal Nanoemulsion Adjuvant and Self-Antigen. Nanomedicine. 7(6). 867–876. 13 indexed citations
10.
Shi, Xiangyang, Inhan Lee, Xisui Chen, et al.. (2010). Influence of dendrimer surface charge on the bioactivity of 2-methoxyestradiol complexed with dendrimers. Soft Matter. 6(11). 2539–2539. 77 indexed citations
11.
Shi, Xiangyang, Su He Wang, Mary E. Van Antwerp, Xisui Chen, & James R. Baker. (2009). Targeting and detecting cancer cells using spontaneously formed multifunctional dendrimer-stabilized gold nanoparticles. The Analyst. 134(7). 1373–1373. 73 indexed citations
12.
Shi, Xiangyang, Su He Wang, Inhan Lee, Mingwu Shen, & James R. Baker. (2009). Comparison of the internalization of targeted dendrimers and dendrimer‐entrapped gold nanoparticles into cancer cells. Biopolymers. 91(11). 936–942. 43 indexed citations
13.
Wang, Su He, Xiangyang Shi, Xisui Chen, & James R. Baker. (2009). Therapeutic Efficacy of 2‐Methoxyestradiol Microcrystals Encapsulated within Polyelectrolyte Multilayers. Macromolecular Bioscience. 9(5). 429–436. 16 indexed citations
14.
Wang, Su He, et al.. (2006). No Apparent Damage in the Thyroid of Transgenic Mice Expressing Antiapoptotic FLIP. Thyroid. 16(1). 1–8. 114 indexed citations
15.
16.
Wang, Su He, Emese Mezősi, Julie M. Wolf, et al.. (2003). IFNγ sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression. Oncogene. 23(4). 928–935. 26 indexed citations
17.
Mezősi, Emese, Hiroko Yamazaki, James D. Bretz, et al.. (2002). Aberrant Apoptosis in Thyroid Epithelial Cells from Goiter Nodules. The Journal of Clinical Endocrinology & Metabolism. 87(9). 4264–4272. 14 indexed citations
18.
19.
Chen, Gong, Su He Wang, & Timothy D. Warner. (2000). Regulation of iNOS mRNA levels in endothelial cells by glutathione, a double-edged sword. Free Radical Research. 32(3). 223–234. 25 indexed citations
20.
Chen, Gong, Elizabeth G. Wood, Su He Wang, & Timothy D. Warner. (1999). Expression of cyclooxygenase-2 in rat vascular smooth muscle cells is unrelated to nuclear factor-κB activation. Life Sciences. 64(14). 1231–1242. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Venkata Vamsi Krishna Venuganti Breakdown of academic impact, for papers by Linlin Tang Breakdown of academic impact, for papers by Omathanu Pillai Breakdown of academic impact, for papers by Shraddha S. Nigavekar Breakdown of academic impact, for papers by Shiyan Guo Breakdown of academic impact, for papers by Hanh Thuy Nguyen Breakdown of academic impact, for papers by Xinru You Breakdown of academic impact, for papers by Bijay Kumar Poudel Breakdown of academic impact, for papers by Anna Mero Breakdown of academic impact, for papers by Emilie Roger
Rankless by CCL
2026